Orion closes down Danish manufacturing
Troubled Finnish group Orion has decided to close down its pharmaceutical manufacturing operations in Denmark in a bid to save money.
Troubled Finnish group Orion has decided to close down its pharmaceutical manufacturing operations in Denmark in a bid to save money.
Novo Nordisk has enlisted the aid of the USA's Morphotek to improve the manufacturing process for one of its marketed protein therapeutics.
Nitto Denko is to buy Elan Transdermal Technologies in the first stage of a strategy to roll-out Nitto's drug delivery technologies around the world.
Whatman has decided to wind down the operations of its German subsidiary Biometra, taking a £10.1 million charge in the process. The move fends off a patent infringement challenge from Applied Biosystems.
Australia's Biotechnology Frontiers is awarded a A$780,000 grant to develop a microbiological quality control tool that can be used in the pharma and food industries.